Athenex: Latest Data Makes A Paradigm Shift In Current Standard Of Care For Cancer Treatment [Seeking Alpha]
Athenex, Inc. (ATNX)
Last athenex, inc. earnings: 2/27 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.athenex.com
Company Research
Source: Seeking Alpha
Athenex: Latest Data Makes A Paradigm Shift In Current Standard Of Care For Cancer Treatment Summary Athenex reported positive results in a phase 3 study using oral paclitaxel to treat patients with metastatic breast cancer. The key advantage of the company involves its orascovery platform which utilizes an inhibitor of P-glycoprotein known as enciquidar, which allows chemotherapy to be given in oral form. There was an improvement in safety. This is noted in the released safety data showing 17% of oral paclitaxel patients having neuropathy as opposed to 57% for those on placebo. The orascovery platform is not just being applied to paclitaxel, it can be used on all other types of chemotherapy like irinotecan, topotecan, docetaxel and eribulin. ATNX reported positive results from its phase 3 study Phase 3 Study Meets Goal Of Providing New Treatment Option For Standard Of Care The phase 3 study recruited a total of 402 patients with metastatic breast cancer. Patients were either given or
Show less
Read more
Impact Snapshot
Event Time:
ATNX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATNX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATNX alerts
High impacting Athenex, Inc. news events
Weekly update
A roundup of the hottest topics